Document is current
Any future updates will be listed below
-
Authors
Negrin, Robert S.
- License Information
-
More Information
Article History
First Online: 20 August 2019
Compliance with ethical standards
:
: The author received consulting fees from Amgen and Jazz Pharmaceuticals, owns equity in Magenta and BioEclipse, performs occasional medical legal work, and serves as Editor in Chief of <i>Blood Advances</i>.
